The ruling sends a warning to drug makers that try to deter generic rivals from entering the market by settling potential patent claims, paying the competitors to stay out of the market for years more. That enables the brand-name…
Comment:*
Nickname*
E-mail*
Website
Save my name, email, and website in this browser for the next time I comment.
